|
Volumn 116, Issue 5, 1999, Pages 1266-1267
|
Making end points meet.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
AMINOTRANSFERASE;
BIOLOGICAL MARKER;
RIBAVIRIN;
VIRUS RNA;
ARTICLE;
BLOOD;
DRUG COMBINATION;
HEPATITIS C;
HUMAN;
LIVER FAILURE;
MORTALITY;
PROSPECTIVE STUDY;
SURVIVAL RATE;
TREATMENT OUTCOME;
VIRUS LOAD;
BIOLOGICAL MARKERS;
DRUG THERAPY, COMBINATION;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
LIVER FAILURE;
PROSPECTIVE STUDIES;
RIBAVIRIN;
RNA, VIRAL;
SURVIVAL RATE;
TRANSAMINASES;
TREATMENT OUTCOME;
VIRAL LOAD;
|
EID: 0033126556
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0016-5085(99)70036-3 Document Type: Article |
Times cited : (3)
|
References (0)
|